In this recent interview, Dr. Kawsar Talaat advises those at greater risk for developing blood clots after vaccine administration to discuss risks and benefits with their health care provider or other trusted person in order to make an informed decision on what vaccine may be best for them. Full story here…
If the newly-approved one dose Johnson & Johnson COVID-19 vaccine is offered in low-income and minority communities in preference to their Pfizer and Moderna counterparts, will it be perceived as another slight by these communities due to questions surrounding it’s effectiveness? Public health and bioethics experts Drs. Ruth Karron and Ruth Faden discuss an option […]
Booster shots, second-generation vaccines: COVID-19 vaccine makers rush to adapt to coronavirus variants
CIR Principal Investigator Dr. Durbin discusses plans for COVID-19 vaccine makers to combat new virus strains while continuing the roll out of currently licensed vaccines.
Some parents and children are wondering when the licensed COVID-19 vaccines will become available to children younger than 16 years old. NIAID Director Dr. Anthony Fauci and CIR Principal Investigator Dr. Kawsar Talaat are featured in this WUSA9 story which aims to verify the vaccine roll-out timeline for children in this age group.
Dr. Karron participated in the show’s third segment, called COVID-19 Vaccine 101, where she addressed topics like the nature of mRNA vaccines, vaccine hesitancy and myths including the unsubstantiated beliefs that COVID19 vaccines contain microchips and have the ability to change DNA.
CIR Director Dr. Ruth Karron and faculty member Jessica Atwell answer Frequently Asked Questions regarding EUAs and COVID vaccine licensure.